N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study ; volume:24 ; number:1 ; day:29 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
Trials ; 24, Heft 1 (29.5.2023), 1-9, 12.2023
- Creator
-
Fields, T.
M. Bremova, T.
Billington, I.
Churchill, GC
Evans, W.
Fields, C.
Galione, A.
Kay, R.
Mathieson, T.
Martakis, K.
Patterson, M.
Platt, F.
Factor, M.
Strupp, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-023-07399-6
- URN
-
urn:nbn:de:101:1-2023091109460845226285
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fields, T.
- M. Bremova, T.
- Billington, I.
- Churchill, GC
- Evans, W.
- Fields, C.
- Galione, A.
- Kay, R.
- Mathieson, T.
- Martakis, K.
- Patterson, M.
- Platt, F.
- Factor, M.
- Strupp, M.
- SpringerLink (Online service)
Other Objects (12)
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
Niemann-Pick type C disease: effects of a therapy with acetyl-DL-leucine and vestibular function
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series
Morbus Niemann-Pick
Niemann-Pick disease
Niemann-Pick disease type C
Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
Treatment trials in Niemann-Pick type C disease
Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR)
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
Niemann-Pick type C disease: effects of a therapy with acetyl-DL-leucine and vestibular function
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series
Morbus Niemann-Pick
Niemann-Pick disease
Niemann-Pick disease type C
Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
Treatment trials in Niemann-Pick type C disease
Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR)
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
Niemann-Pick type C disease: effects of a therapy with acetyl-DL-leucine and vestibular function
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series
Morbus Niemann-Pick
Niemann-Pick disease
Niemann-Pick disease type C
Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report
Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
Treatment trials in Niemann-Pick type C disease